| Product Code: ETC5821306 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Biologics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Biologics Market - Industry Life Cycle |
3.4 Israel Biologics Market - Porter's Five Forces |
3.5 Israel Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Israel Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Israel Biologics Market Revenues & Volume Share, By Disease? Category, 2021 & 2031F |
3.8 Israel Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2021 & 2031F |
4 Israel Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing investments in research and development in the biologics sector |
4.2.3 Favorable government regulations and policies supporting biologics market growth |
4.3 Market Restraints |
4.3.1 High costs associated with biologics development and production |
4.3.2 Stringent regulatory requirements for approval and commercialization of biologics |
5 Israel Biologics Market Trends |
6 Israel Biologics Market Segmentations |
6.1 Israel Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Israel Biologics Market Revenues & Volume, By Microbial, 2021-2031F |
6.1.3 Israel Biologics Market Revenues & Volume, By Mammalian, 2021-2031F |
6.1.4 Israel Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.2 Israel Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.2.3 Israel Biologics Market Revenues & Volume, By Vaccines, 2021-2031F |
6.2.4 Israel Biologics Market Revenues & Volume, By Recombinant Proteins, 2021-2031F |
6.2.5 Israel Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2021-2031F |
6.2.6 Israel Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.3 Israel Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Israel Biologics Market Revenues & Volume, By Oncology, 2021-2031F |
6.3.3 Israel Biologics Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.3.4 Israel Biologics Market Revenues & Volume, By Immunological Disorders, 2021-2031F |
6.3.5 Israel Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2021-2031F |
6.3.6 Israel Biologics Market Revenues & Volume, By Hematological Disorders, 2021-2031F |
6.3.7 Israel Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.4 Israel Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Israel Biologics Market Revenues & Volume, By Outsourced, 2021-2031F |
6.4.3 Israel Biologics Market Revenues & Volume, By In-house, 2021-2031F |
7 Israel Biologics Market Import-Export Trade Statistics |
7.1 Israel Biologics Market Export to Major Countries |
7.2 Israel Biologics Market Imports from Major Countries |
8 Israel Biologics Market Key Performance Indicators |
8.1 Research and development (RD) investment in biologics |
8.2 Number of approved biologics in the market |
8.3 Adoption rate of biologics in healthcare facilities |
8.4 Number of clinical trials for new biologics |
8.5 Patents filed and granted for biologics innovations |
9 Israel Biologics Market - Opportunity Assessment |
9.1 Israel Biologics Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Israel Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Israel Biologics Market Opportunity Assessment, By Disease? Category, 2021 & 2031F |
9.4 Israel Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2021 & 2031F |
10 Israel Biologics Market - Competitive Landscape |
10.1 Israel Biologics Market Revenue Share, By Companies, 2024 |
10.2 Israel Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here